Slingshot Insights | I7 G.f Overview

I7G.F Overview

Upcoming Projects (I7G.F)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (I7G.F)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (I7G.F)

Exelixis and Its Partner Ipsen Announce Phase 3 Trial Results of CABOMETYX (Cabozantinib) Tablets Demonstrating Significant Overall Survival Benefit for Previously Treated Patients with Advanced Renal Cell Carcinoma Presented at ASCO
Tickers: EXEL, I7G.F
Occurred on: Jun 05, 2016

Strategic Initiatives (I7G.F)

Don’t see a strategic initiative related to the company you care about? Create your own!